For years, PPC advertisers have considered Performance Max (and Smart Shopping before it) to be a black box, even a black hole. While its powerful automation drives convincing results, the lack of ...

Throughout 2025, the Office of the Comptroller of the Currency (OCC) has taken the lead on expanding banks’ ability to engage in cryptocurrency-related activities without the need for a supervisory ...

Washington is weighing whether to offer Ukraine NATO-style security guarantees, a move critics warn could dramatically raise the risk of direct conflict with Russia. Supporters argue such commitments ...

In today’s "Crypto for Advisors" newsletter, Harvey Li from Tokenization Insights takes us through tokenization trends, money market funds, and institutional adoption as we head into 2026. Then, in ...

Further Asset Management has announced that it has entered into a Memorandum of Understanding with Canton Network to advance blockchain infrastructure in the Middle East. Under the agreement, Further ...

Ghana’s Parliament has passed the Virtual Asset Service Providers (VASPs) Bill, marking a major step toward the regulation of virtual assets and digital finance activities in the country. In a press ...

In 2026, Canada’s national unity will be put to the test in more ways than one. We have separatist movements gaining steam in Alberta, Saskatchewan and Quebec and a separatist agitator running the ...

For all fund investors, NAV is supposed to stand for “net asset value.” For some, however, it’s turning out to mean “not actual value.” That’s the hard lesson of recent weeks when some funds that ...

Acquired assets further optimize Vireo’s operating footprint in Colorado with addition of 17 dispensaries Transaction expands Vireo’s leadership position in the Colorado retail market with 41 total ...

With a late-stage miss reported for its prospective social anxiety disorder (SAD) treatment fasedienol, Vistagen’s chances at an FDA approval in the indication are looking slimmer. That said, the ...

Ipsen may be a recent entrant into the antibody-drug conjugate space, but the French biopharma is continuing to make up for lost time. The latest addition to the Paris-based company’s portfolio is ...

The Prime Minister and the Minister for Home Affairs indulged in some world-class gaslighting on Monday when they said a royal commission on anti-Semitism would "platform" anti-Semites and ...